Dextro-Amphetamin

TERMINATED · PHASE4 · Stroke

Intended length of study ended

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.